Neuronetics: 2Q Earnings Snapshot
MALVERN, Pa. (AP) _ Neuronetics Inc. (STIM) on Tuesday reported a loss of $7.1 million in its second quarter.
The Malvern, Pennsylvania-based company said it had a loss of 39 cents per share.
The medical device company focused on psychiatric disorders posted revenue of $16.6 million in the period.
For the current quarter ending in October, Neuronetics said it expects revenue in the range of $15.8 million to $16.4 million.
The company expects full-year revenue in the range of $63 million to $65 million.
Neuronetics shares have dropped 46% since the beginning of the year. The stock has declined 58% in the last 12 months.